ABSTRACT
Synthetic cannabinoids (SCs), colloquially spice or K2, are the most common drug to be found in prisons in the UK, where they are associated with nearly half of non-natural deaths. In the community, SCs are associated with poly-drug users who are also likely to be homeless. People who use SCs report debilitating side effects and withdrawal symptoms, coupled with dependence. Until now, SC use was believed to be largely restricted to prison and homeless populations. However, media reporting in the UK has increasingly identified cases of children collapsing in schools, which are claimed to be associated with vaping and putatively the vaping of a drug, variously reported as tetrahydrocannabinol (THC) ‘synthetic cannabis’ or ‘spice’. We therefore conducted the first study to identify and quantity SCs in e-cigarettes routinely collected from schools. We sampled 27 schools from geographically distinct regions of England, representing a very broad range of social metrics (free school meals, persistent absenteeism, and SEN). The material was sampled by self-submission by individual schools of e-cigarettes seized during normal school operation and transferred to us for analysis via local police forces. We found a remarkably consistent picture where SCs were detected in 17.5 % of all e-cigarettes sampled, and in 21 of 27 (78 %) of all sampled schools. Moreover, the percentage of SC e-cigarettes positively correlated with a metric of social deprivation, the fraction of pupils eligible for free school meals. The SC positive e-cigarettes were almost entirely found in e-cigarette liquid bottles and refillable e-cigarette devices, with very few identified in single use e-cigarette products. Within the positive samples we found an average SC concentration of 1.03 mg mL-1 with a maximum of 3.6 mg mL-1. In contrast to the high prevalence of SCs, few samples contained THC (1.6 %). We suggest that pupils are being sold SC e-cigarettes as ‘cannabis’ and may be unaware they are consuming (and sometimes supplying) considerably more harmful drugs. Our findings are immediately crucial to policy policing and healthcare in the UK as well as to educational bodies and schools.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Pudney acknowledges the EPSRC for funding (EP/V026917/1 and EP/L016354/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
ABBREVIATIONS
- SC
- synthetic cannabinoid
- THC
- tetrahydrocannabinol
- LC/GC-MS
- liquid/gas chromatography-mass spectrometry
- NMR
- nuclear magnetic resonance